Dmytro Shymkiv gave his forecast of the future impact of coronavirus on business

 

The Covid-19 coronavirus pandemic and related quarantine restrictions have led to a decrease in profits in certain areas of business by up to 80%. This was stated by the chairman of the board of directors of Darnitsa Group, Dmytro Shymkiv.

 

 

According to him, in such harsh conditions, only adaptive companies can survive, which are able to adapt to new realities, can find new forms of cooperation with customers, actively use innovative technologies and implement IT developments. According to the forecasts of analysts and experts, in 2021 various digital platforms, messengers and chats, delivery services and real estate trade will continue to develop and be popularized. It will be the hardest for builders, developers and owners of office premises and commercial real estate. This state of things can be explained quite simply: remote working reduces the demand for renting offices and shops, but more and more people want to have a separate room at home for work or sports.

 

According to the top manager, another trend triggered by the coronavirus crisis and quarantines is de-urbanization. Urban residents, in order to protect themselves and their loved ones from the risk of infection, seek to limit the number of social contacts that are inevitable in these living conditions. Therefore, they move out of town, live there and work remotely.

 

Despite the times of crisis, Darnitsa Group continues to actively invest in new research and development. Moreover, the pandemic has given impetus to the implementation of projects that were previously only discussed. Now, the pharmaceutical company “Darnitsa” is systematically introducing the latest IT technologies into its production, working on increasing the number of in silico studies, which are based on computer modelling of biological experiments. All this will make it possible to predict the consequences of diseases and the outcome of therapy faster and more accurately, which means that the pharmaceutical industry will be able to produce new, much more effective drugs with fewer side effects.

 

As for “Darnitsa”, Dmytro Shymkiv said that the company is currently working on more than 50 names of drugs, which are at different stages of development and research. Their official registration is scheduled for 2023. Most of these drugs deal with pain, heart and nervous system problems.